AKT1 and central nervous system cancer: Collectively, these results demonstrated that knockdown of CBX3 reversed LINC00998 overexpression-mediated suppression of malignant phenotypes of glioma cells and Akt/mTOR signaling pathway key protein phosphorylation levels.